Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-28 @ 5:55 AM
Study NCT ID:
NCT00405366
Status:
COMPLETED
Last Update Posted:
2017-04-18
First Post:
2006-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2009-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-28
First Submit QC Date:
None
Study First Post Date:
2006-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-17
Last Update Post Date:
2017-04-18
Last Update Post Date Type:
ACTUAL